Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival - Wikidata - wikimedia - TriplyDB

Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival

Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival

http://www.wikidata.org/entity/Q28568576

about

Multidrug resistance-associated protein 4 regulates cAMP-dependent signaling pathways and controls human and rat SMC proliferation Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications Vinpocetine inhibits NF-kappaB-dependent inflammation via an IKK-dependent but PDE-independent mechanism Regulation of phosphodiesterase 3 and inducible cAMP early repressor in the heart Lentiviral-Mediated shRNA Silencing of PDE4D Gene Inhibits Platelet-Derived Growth Factor-Induced Proliferation and Migration of Rat Aortic Smooth Muscle Cells Ribosomal protein L17, RpL17, is an inhibitor of vascular smooth muscle growth and carotid intima formation Cyclic nucleotide phosphodiesterase 1A: a key regulator of cardiac fibroblast activation and extracellular matrix remodeling in the heart Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.Vinpocetine attenuates neointimal hyperplasia in diabetic rat carotid arteries after balloon injury.Concerted regulation of cGMP and cAMP phosphodiesterases in early cardiac hypertrophy induced by angiotensin II The PDE1A-PKCalpha signaling pathway is involved in the upregulation of alpha-smooth muscle actin by TGF-beta1 in adventitial fibroblasts.Phosphodiesterase 10A upregulation contributes to pulmonary vascular remodeling Cardiac cyclic nucleotide phosphodiesterases: function, regulation, and therapeutic prospects.Cyclic nucleotide phosphodiesterase 1 regulates lysosome-dependent type I collagen protein degradation in vascular smooth muscle cells Advances in targeting cyclic nucleotide phosphodiesterases cGMP-dependent protein kinases and cGMP phosphodiesterases in nitric oxide and cGMP action.Targeting cyclic nucleotide phosphodiesterase in the heart: therapeutic implications.Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets.Phosphodiesterase 4B mediates extracellular signal-regulated kinase-dependent up-regulation of mucin MUC5AC protein by Streptococcus pneumoniae by inhibiting cAMP-protein kinase A-dependent MKP-1 phosphatase pathway.Cyclic nucleotide phosphodiesterase 1 and vascular aging Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration.Old dog, new tricks: novel cardiac targets and stress regulation by protein kinase G.Expression and activity of phosphodiesterase isoforms during epithelial mesenchymal transition: the role of phosphodiesterase 4.Cyclic GMP signaling in cardiovascular pathophysiology and therapeutics.Clinical and molecular genetics of the phosphodiesterases (PDEs).PDE1 isozymes, key regulators of pathological vascular remodeling Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments.Phosphodiesterases and cyclic GMP regulation in heart muscle.Compartmentation of cAMP signalling in cardiomyocytes in health and disease.Vinpocetine inhibits breast cancer cells growth in vitro and in vivo.Profiling of cardiac β-adrenoceptor subtypes in the cardiac left ventricle of rats with metabolic syndrome: Comparison with streptozotocin-induced diabetic rats.Generation and phenotypic characterization of Pde1a mutant mice.Regulatory mechanism of human vascular smooth muscle cell phenotypic transformation induced by NELIN.Ca2+/calmodulin-stimulated PDE1 regulates the beta-catenin/TCF signaling through PP2A B56 gamma subunit in proliferating vascular smooth muscle cells Ca2+, calmodulin, and cyclins in vascular smooth muscle cell cycle Phosphodiesterase 1: A Unique Drug Target for Degenerative Diseases and Cognitive Dysfunction.Phosphodiesterase type 5 and cancers: progress and challenges.DNA methylation and obesity traits: An epigenome-wide association study. The REGICOR study.MiR-541-5p regulates lung fibrosis by targeting cyclic nucleotide phosphodiesterase 1A.PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries.

P2860

82749e6f5d263234c1cc9b582a98002ca48f7d62 a58e5ff144fdfbe1dcd8d1ccf7b092d0259bedd1

P248

Q24641873-DC714FB8-34F2-4E8F-BA58-3512DD999220 Q26753116-7E33D6E3-2699-41C6-B55D-2EB7230A2696 Q28281609-25353FD6-F033-4428-8323-47603C126054 Q28291007-54C5FF31-6EBF-43E7-983E-009F9CDDF1F0 Q28565953-62C6F67B-FCAA-4018-8812-6DA45C02D790 Q28573822-A8D149FB-8088-40E6-87BC-CB31DF6239EE Q28574432-ABD4F1CB-6321-43D6-B93B-E24EB7B09102 Q33577131-1D2A2094-D6BA-4D63-BA37-01ECD90DD00E Q33599923-634D4D20-AFA4-4538-BCFD-BBC65E32BA52 Q33769656-2DE70270-02BF-4681-95C9-8F9339FA90A7 Q33792164-6CAE6809-5EB7-48BE-B7A4-B04ACF0520FE Q33873485-6CCC0402-60D2-40BD-AF09-8A2B34FA1572 Q33966155-A0FC7FF7-0BFD-40ED-9636-8B65B9041FDD Q33966213-713D6948-5121-4B47-ACF4-731D5683B0DE Q34139490-A3460B71-FB32-4FBF-9EF5-75D175E9DB31 Q34244951-65B9EE59-1956-481A-8081-FFCCC362A6A8 Q34252901-9C69A193-3A60-46F8-955E-33D5EF8BECDD Q34765802-919C1D30-CF50-4161-BDB5-D9BF9FBB8451 Q36080545-52EFA339-2552-46B6-B315-13292348CA8C Q36175455-F2A052E1-F6A5-4AF3-A309-E0E2BBC4BCD5 Q36335468-A3D5BAB2-FE33-4F15-A7DC-C3F782252DCA Q37075920-9230DB42-9DDB-4788-A4D6-0FF2F59A70D9 Q37420468-C8B58498-56BB-42A2-BDFB-5E67DDE2D9A8 Q37420916-10C7A0A3-1CDD-4996-A971-EFB30EB55BB7 Q37657841-4478D6C8-FF67-4BE6-98AA-A726BE35C3B5 Q37941150-3F774026-2EC1-4A7F-A74E-4BE547BD8C20 Q37947681-AD357F9C-3DE5-403F-A7A0-AEB822D13947 Q38033089-27B15A20-90DF-4387-BFF7-939EE80A7BBF Q38079253-CA28055B-7149-4B28-A724-6AC893C521EE Q39325929-7FE699F0-0BED-4BE4-A246-FEF2F8A92253 Q40918549-FF3A1DDB-C408-4C88-8B39-B0AC7205176A Q41153428-049023DC-3F29-4EAF-8E3E-FCE07FF2C36E Q42174392-50BC0EE1-FD4D-4723-B3E3-74DDB81D8DBF Q42176198-BC58D4BF-2879-4803-8B89-CFA65978B554 Q42416262-92B83B94-80CC-49CB-8F1A-0B9E398F86AC Q42515895-D79D82F2-8534-4DC2-B291-77C1EB1225F5 Q47171803-43672973-8A4C-4D76-9634-B0E6BA665486 Q47664009-2093210C-0997-40AA-845C-B0230DB1156E Q47941661-CDD27086-19C6-4095-8EC7-CDF2584ACF64 Q48345105-533C4F1B-0533-4EA3-8690-BDB933E78C7F

P2860

Role of nuclear Ca2+/calmodulin-stimulated phosphodiesterase 1A in vascular smooth muscle cell growth and survival

http://www.wikidata.org/entity/Q28568576

description

2006 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի մարտին հրատարակված գիտական հոդված

@hy

artículu científicu espublizáu en 2006

@ast

im März 2006 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

vedecký článok (publikovaný 2006/03/31)

@sk

vědecký článek publikovaný v roce 2006

@cs

wetenschappelijk artikel (gepubliceerd op 2006/03/31)

@nl

наукова стаття, опублікована в березні 2006

@uk

مقالة علمية (نشرت في 31-3-2006)

@ar

name

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@ast

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@en

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@nl

type

label

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@ast

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@en

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@nl

prefLabel

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@ast

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@en

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@nl

P1433

Q28568576-9386E254-ECC0-44DB-AC21-02E0807AFC10

P1476

Q28568576-5B53B5A3-4858-4BE1-A516-41E3EC16E28F

P2093

Q28568576-01F737C0-A2F7-41A3-BA6B-4F4AF9BD7717

Q28568576-040931AC-E485-4CC5-9103-6085EA4DDA78

Q28568576-067E1FDE-03B7-4517-83A8-C8CD7EFD9805

Q28568576-0BA405CA-A012-435F-AAC0-76E2DF491FA1

Q28568576-33E910B4-628A-4F66-8256-693B2A468DF4

Q28568576-4531E999-7443-47D6-B2AF-975F65DD42EE

Q28568576-767C45C1-BADF-413F-B26B-FA25F62B072D

Q28568576-ACAB0D64-3037-4677-9A50-24728871DFF5

Q28568576-AF833E81-1694-48E4-818E-56EC3AD465A2

Q28568576-BEA9B74F-F9B9-4E26-95C7-DD35EC4FF952

P2860

Q28568576-018CCE3C-5C29-42E6-A437-B06B4A8E8493

Q28568576-053BB3C4-E56B-40F7-A823-B680C44875BB

Q28568576-097F7514-9FAA-4B9F-AF46-3BC5CFA039FE

Q28568576-1A064E1C-6C5C-4471-8F61-336C5E4B56B5

Q28568576-4B2547DA-4FCA-46D2-B53F-BBC4988D5A32

Q28568576-580CEF7A-4A27-4DAA-B088-CA334B0217CC

Q28568576-584026E4-B79C-4E1F-BD54-CA236C89F48F

Q28568576-5A78A7B0-CA0C-40DF-B38F-7982741B6C19

Q28568576-66966681-FA04-4E81-91BA-8B5230B1CBF3

Q28568576-68222A9A-8A36-4A70-B18C-B3645E90B68D

P304

Q28568576-DFABC19D-C360-4FAF-88F4-F68EF9E7EB54

P31

Q28568576-64682F37-9078-4AB1-BAAE-198768C62D9D

P3181

Q28568576-D36ADF1E-AA6E-4D18-998A-6C904EFD3269

P356

Q28568576-A48FE75E-6349-4509-ACA1-F65FFC5A891B

P433

Q28568576-E793E70B-3280-41DA-9C62-43F3CCAD2F36

P478

Q28568576-541D7104-32F2-4059-9303-EC04E6A80CAC

P50

Q28568576-3D97C530-2316-4E83-9F62-1372F483A5EF

P577

Q28568576-9BD39ADC-7F09-4A36-86D3-5388ED7DF5D2

P5875

Q28568576-71929ECD-1962-4202-89B5-E1010D84D079

P698

Q28568576-B42E62DB-43F7-49A1-B03E-B2001FE753FB

P932

Q28568576-C219061F-12F6-4CCD-B917-FE75720988B1

P3181

P356

01.RES.0000215576.27615.FD

P1433

Circulation Research

P1476

Role of nuclear Ca2+/calmoduli ...... uscle cell growth and survival

@en

P2093

Amy Mohan

http://www.w3.org/2001/XMLSchema#string

Chen Yan

http://www.w3.org/2001/XMLSchema#string

David J Nagel

http://www.w3.org/2001/XMLSchema#string

Heng Wei

http://www.w3.org/2001/XMLSchema#string

Joseph M Miano

http://www.w3.org/2001/XMLSchema#string

Kye-Im Jeon

http://www.w3.org/2001/XMLSchema#string

Pingjin Gao

http://www.w3.org/2001/XMLSchema#string

Toru Aizawa

http://www.w3.org/2001/XMLSchema#string

Vincent A Florio

http://www.w3.org/2001/XMLSchema#string

Vyacheslav A Korshunov

http://www.w3.org/2001/XMLSchema#string

P2860

A role for ATR in the DNA damage-induced phosphorylation of p53

Atherosclerosis — An Inflammatory Disease

Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle

3',5'-cyclic nucleotide phosphodiesterase 11A: localization in human tissues

DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2

Effects of vinpocetine on cyclic nucleotide metabolism in vascular smooth muscle

Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling

The pathogenesis of atherosclerosis: a perspective for the 1990s

Molecular regulation of vascular smooth muscle cell differentiation in development and disease

Mammalian G1 cyclins

P304

777-784

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4915392

http://www.w3.org/2001/XMLSchema#string

P356

10.1161/01.RES.0000215576.27615.FD

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

98

http://www.w3.org/2001/XMLSchema#string

P50

Bradford C. Berk

P577

2006-03-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7264033

http://www.w3.org/2001/XMLSchema#string

P698

16514069

http://www.w3.org/2001/XMLSchema#string

P932

4114760

http://www.w3.org/2001/XMLSchema#string